Other antibiotics for topical use
Bacitracin Zinc and Polymyxin B Sulfate
The FDA lists this product in 3 strengths and forms.
Indications
For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate.
Contraindications
This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Warnings and precautions
Ophthalmic ointments may retard corneal healing.
Adverse reactions
To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Composition
- Active ingredients
- BACITRACIN ZINC 500 UNITS/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BACITRACIN ZINC 500 UNITS/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM · OintmentThis page
- BACITRACIN ZINC 500 UNITS/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM · OintmentANDA064028-001 · Discontinued
- BACITRACIN ZINC 500 UNITS/GM; POLYMYXIN B SULFATE 10,000 UNITS/GM · OintmentANDA065022-001 · Discontinued